Presentations from Top Biopharma in 2026

Intact Quantitation of Cysteine‐Conjugated Antibody‐Drug Conjugates Using Native Mass Spectrometry
Hetal Sarvaiya, Director, QTAS, AbbVie, Inc.

Freeze/Thaw of Biologicals: Degradation Mechanisms and Stabilization Strategies
Evgenyi Y. Shalaev, PhD, FAAPS, Distinguished Research Fellow, Pharmaceutical Sciences, Abbvie, Inc.


High-Throughput Viscosity Screening Enables AI-Driven Structure Modeling for Biotherapeutic Design
Alayna George Thompson, PhD, Associate Director, Drug Product Development, AbbVie

Application of SPR Chaser Assay to Study Biomolecular Interactions with Very Slow Off Rate
Wei Wang, PhD, Senior Principal Scientist, Therapeutic Discovery, Amgen, Inc.

Expanding and Optimizing Purification and Analytical Capabilities for High-Throughput Screening
Daniel Yoo, Scientific Associate Director, Large Molecule Discovery & Research Data Science, Amgen, Inc.

From Gene to Protein, Uninterrupted: The Power of Workcell Automation in Accelerating Discovery
Pei-Hsuan Chu, Associate Director, AstraZeneca

Ada: An Integrated Robotics Work Cell for High-Throughput Functional Assessment of Complex Biologics
Jennifer Houtmann, Senior Assay and Automation Scientist, Biologics Engineering, AstraZeneca

Advancing Preclinical Immunogenicity Prediction: Machine Learning on Clinical Data and Pathogen Cross-Reactivity Integration
Olga Obrezanova, PhD, AI Principal Scientist, Biologics Engineering, Oncology R&D, AstraZeneca

Accelerating Multispecific Antibody Production and Purification: Novel Technologies and Automation for High-Throughput, Multi-Milligram Yields
Ayla Sessions, Associate Director, AstraZeneca

Precision by Design: Next-Generation Immune Engagers with Improved Therapeutic Index
Even Walseng, PhD, Director, Biologics Engineering, AstraZeneca

Early High-Throughput Optimization of Expression Conditions Enabling Streamlined Purification Processes
Cristian Alberto, Senior Associate Scientist, Bristol Myers Squibb

Strategic Derisking of ADC Molecules: Leveraging in silico, MAPPs, and in vitro Tools
Daron Forman, PhD, Senior Principal Scientist, Discovery Biotherapeutics, Bristol Myers Squibb

High-Throughput Reagent Production to Enable Biotherapeutics Discovery
Holly Schmidt, Senior Principal Scientist, Bristol Myers Squibb

Controlling Gastric Delivery of a GIP/GLP1 Peptide in Monkeys by Mucoadhesive SNAC Tablets
Huyen Tran, PhD, Director, Formulation Research, Eli Lilly & Company

New Frontier of Biotherapeutic Discovery: Where Machine Learning Meets Molecular Design
Stephanie Truhlar, PhD, Vice President, Biotechnology Discovery Research, Eli Lilly and Company

Advancements in Protein-Expression Workflows for Drug Discovery
Kanika Bajaj Pahuja, PhD, Senior Scientific Manager, Protein Sciences, Genentech

ML-Guided Venom Library Design: Innovations and Applications
Fei Cai, PhD, Principal Scientific Researcher, Genentech Inc.

Affinity Analysis of Novel Binders and Target Specificity
Eric Janezic, PhD, Principal Scientist, Genentech Inc.

Redefining Drug Discovery with AI
Yinyin Li, PhD, Principal Scientist, Biochemical & Cellular Pharmacology, Genentech, Inc.

Application of Molecular Interaction Characterization in Support of Bioanalysis of Therapeutics
Xiangdan Wang, PhD, Senior Principal Scientist, BioAnalytical Sciences, Genentech, Inc.

Predicting Purification Process Fit of Monoclonal Antibodies Using Machine Learning
Andrew J. Maier, Principal Engineer, Purification Development, Genentech, Inc.

High-Throughput Multi-Dimensional Chromatography Configuration for Purification of Large Molecule Therapeutics at Research Scale
Ian Scott, Scientist, Protein Therapeutics, Gilead Sciences

Preformulation Strategies for ADC Development
Mona Goli, PhD, Senior Scientist, Cell Engineering, Johnson & Johnson

Strategies for Expressing Complex Multi-Pass Protein Targets
Puneet Khandelwal, PhD, Associate Director, Biologics Discovery-Therapeutic Discovery, Johnson & Johnson Innovative Medicine

Rethinking Biologics Purification in the Lab of the Future
Sidharth Mohan, PhD, Senior Principal Scientist, High-Throughput Expression Sciences, Biologics Discovery, Johnson & Johnson Innovative Medicine

Assays Driving Therapeutic Antibody and Biologic Recombinant Production
Dongjun Peng, PhD, Antibody Discovery, Therapeutics Discovery, Johnson & Johnson

Harnessing the Power of Incremental Innovation in a Protein-Biochemistry Lab
Christa Cortesio, PhD, Director, Protein Biochemistry & Analytics Core, Kite, a Gilead Company

Next-Generation Shake Flasks: Can We Reach Bioreactor-Level Performance?
Vikash Kumar, Senior Scientist, Biologics Process Research and Development, Merck

NMR Insights into Solution Behavior and Formulation Challenges of Novel Biologics and High-Concentration Mabs
Mark McCoy, PhD, Senior Principal Scientist, Quantitative Biosciences, Merck

Automation of Biochemical Assays Using an Open-Sourced, Inexpensive Robotic Liquid Handler
George Moukarzel, PhD, Senior Scientist, Merck & Co., Inc.

Automated, Quantitative Capillary Western Blots to Analyze Host Cell Proteins in COVID-19 Vaccine Produced in Vero Cell Line
Richard R. Rustandi, PhD, Senior Research Scientist, Vaccine Analytical R&D, Merck & Co.

Nanoflow Cytometry for AAV/LV Highlight
Chelsey Mattison, Senior Scientist, Novartis

KEYNOTE PRESENTATION: Automation for Rapid Large-Scale Data Generation of Biologics
James D. Love, PhD, Vice President, Cross Modality Workflows, Novo Nordisk AS

FEATURED PRESENTATION: Structure-Aided Design and Engineering of an FGFR1c x KLB Multispecific AltibodyTM Agonist for MASH
Yang Shen, PhD, Executive Director of Antibody Engineering, Bispecifics, Regeneron

FEATURED PRESENTATION: Application and Opportunities for AI/ML in Immunogenicity Risk Prediction
Timothy Hickling, PhD, former Immunogenicity Expert Scientist, Investigative & Immunosafety Chapter, Roche

Building an AI-Native Platform for Accelerated Biologics Discovery at Sanofi
Yves Fomekong Nanfack, PhD, Executive Director & Head, End-to-End AI Foundations, Large Molecules Research Platform, Sanofi

Rapid Affinity-Based Purification of Multispecific Antibodies Using Kappa Select and Protein L
David J. Reczek, PhD, Head of US Biologics Research, Large Molecules Platform, Sanofi

Accelerating Multispecific Antibody Production: Integrating Mini-Scale Affinity Chromatography into High-Throughput uHPLC Workflows
Nicholas Santos, Senior Associate Scientist, Large Molecule Research, Sanofi

Advancing mRNA Platform Technologies: Integrating Analytics, Manufacturing, and Regulatory Strategies
Philip White, PhD, Project Head, Global Research, Sanofi

As of September 25, 2025. Please see individual agenda pages for most up-to-date agenda.